Galectin and Myc enable cochlear progenitor expansion in vitro and in vivo
- bioRxiv. 2026 Jun 7:2026.06.03.729765. doi: 10.64898/2026.06.03.729765.
- 1. Department of Otolaryngology - Head and Neck Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 2. Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 3. Department of Otolaryngology, University of Texas Medical Branch, Galveston, TX 77551, USA.
- 4. Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, M4N 3M5, Canada.
- 5. Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- 6. Department of Natural Sciences, Merrimack College, North Andover, MA 01845, USA.
- 7. Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305, USA.
- 8. Department of Otolaryngology-Head and Neck Surgery, Epithelial Biology Center, Vanderbilt Center for Stem Cell Biology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
The neonatal cochlear epithelium harbors regenerative capacity, attributable to the transient greater epithelial ridge (GER). After injury, GER cells re-enter the cell cycle, migrate into the damaged organ of Corti, and differentiate into sensory or supporting cells in vivo; in culture, they proliferate to form inner ear organoids. The mechanisms underlying this competence remain unclear. Here, we generated organoids from mouse GER cells and performed single-cell transcriptomics at Organoid initiation. Analysis revealed extracellular matrix reorganization with prominent involvement of galectins. Functional assays combining inhibition and overexpression demonstrated that Galectin-1 and Myc are both necessary and sufficient for Organoid growth. Moreover, Myc overexpression conferred organoid-forming capacity in post-neonatal cochlear epithelial cells after hearing onset, thereby extending the time window for regenerative competence. In vivo, organ of Corti ablation induced Galectin-1 upregulation and GER proliferation, suppressed by Galectin-1 blockade, establishing a model to rekindle proliferative potential in mature cochlear cells.